Global IL-23 Receptor Antagonist Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global IL-23 Receptor Antagonist market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
IL-23 receptor antagonists are a class of biologic drugs that target the IL-23 pathway,specifically by blocking the IL-23 receptor.By inhibiting the IL-23 receptor,these antagonists disrupt the signaling cascade that leads to the production of pro-inflammatory cytokines,which are implicated in the chronic inflammation characteristic of these conditions.
This report is a detailed and comprehensive analysis for global IL-23 Receptor Antagonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
IL-23 receptor antagonists are a class of biologic drugs that target the IL-23 pathway,specifically by blocking the IL-23 receptor.By inhibiting the IL-23 receptor,these antagonists disrupt the signaling cascade that leads to the production of pro-inflammatory cytokines,which are implicated in the chronic inflammation characteristic of these conditions.
This report is a detailed and comprehensive analysis for global IL-23 Receptor Antagonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
- Global IL-23 Receptor Antagonist market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global IL-23 Receptor Antagonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global IL-23 Receptor Antagonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global IL-23 Receptor Antagonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for IL-23 Receptor Antagonist
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
IL-23 Receptor Antagonist market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Ustekinumab
- Briakinumab
- Tildrakizumab
- Guselkumab
- Risankizumab
- Mirikizumab
- Other
Market segment by Application
- Crohn's Disease
- Plaque Psoriasis
- Psoriatic Arthritis
- Other
Major players covered
- Janssen Pharmaceuticals
- Sun Pharma
- Almirall
- China Medical System
- AbbVie Biotechnology
- Eli Lilly
- Teva
- Amgen
- Samsung Bioepis
- Sandoz
- Biocon Biologics
- Celltrion
- Qyuns Therapeutics
- Bio-Thera Solutions
- Huadong Medicine
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
- Chapter 1, to describe IL-23 Receptor Antagonist product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of IL-23 Receptor Antagonist, with price, sales quantity, revenue, and global market share of IL-23 Receptor Antagonist from 2021 to 2026.
- Chapter 3, the IL-23 Receptor Antagonist competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the IL-23 Receptor Antagonist breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and IL-23 Receptor Antagonist market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of IL-23 Receptor Antagonist.
- Chapter 14 and 15, to describe IL-23 Receptor Antagonist sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global IL-23 Receptor Antagonist Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Ustekinumab
1.3.3 Briakinumab
1.3.4 Tildrakizumab
1.3.5 Guselkumab
1.3.6 Risankizumab
1.3.7 Mirikizumab
1.3.8 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global IL-23 Receptor Antagonist Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Crohn's Disease
1.4.3 Plaque Psoriasis
1.4.4 Psoriatic Arthritis
1.4.5 Other
1.5 Global IL-23 Receptor Antagonist Market Size & Forecast
1.5.1 Global IL-23 Receptor Antagonist Consumption Value (2021 & 2025 & 2032)
1.5.2 Global IL-23 Receptor Antagonist Sales Quantity (2021-2032)
1.5.3 Global IL-23 Receptor Antagonist Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Janssen Pharmaceuticals
2.1.1 Janssen Pharmaceuticals Details
2.1.2 Janssen Pharmaceuticals Major Business
2.1.3 Janssen Pharmaceuticals IL-23 Receptor Antagonist Product and Services
2.1.4 Janssen Pharmaceuticals IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Janssen Pharmaceuticals Recent Developments/Updates
2.2 Sun Pharma
2.2.1 Sun Pharma Details
2.2.2 Sun Pharma Major Business
2.2.3 Sun Pharma IL-23 Receptor Antagonist Product and Services
2.2.4 Sun Pharma IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sun Pharma Recent Developments/Updates
2.3 Almirall
2.3.1 Almirall Details
2.3.2 Almirall Major Business
2.3.3 Almirall IL-23 Receptor Antagonist Product and Services
2.3.4 Almirall IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Almirall Recent Developments/Updates
2.4 China Medical System
2.4.1 China Medical System Details
2.4.2 China Medical System Major Business
2.4.3 China Medical System IL-23 Receptor Antagonist Product and Services
2.4.4 China Medical System IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 China Medical System Recent Developments/Updates
2.5 AbbVie Biotechnology
2.5.1 AbbVie Biotechnology Details
2.5.2 AbbVie Biotechnology Major Business
2.5.3 AbbVie Biotechnology IL-23 Receptor Antagonist Product and Services
2.5.4 AbbVie Biotechnology IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 AbbVie Biotechnology Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly IL-23 Receptor Antagonist Product and Services
2.6.4 Eli Lilly IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Eli Lilly Recent Developments/Updates
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva IL-23 Receptor Antagonist Product and Services
2.7.4 Teva IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Teva Recent Developments/Updates
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen IL-23 Receptor Antagonist Product and Services
2.8.4 Amgen IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Amgen Recent Developments/Updates
2.9 Samsung Bioepis
2.9.1 Samsung Bioepis Details
2.9.2 Samsung Bioepis Major Business
2.9.3 Samsung Bioepis IL-23 Receptor Antagonist Product and Services
2.9.4 Samsung Bioepis IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Samsung Bioepis Recent Developments/Updates
2.10 Sandoz
2.10.1 Sandoz Details
2.10.2 Sandoz Major Business
2.10.3 Sandoz IL-23 Receptor Antagonist Product and Services
2.10.4 Sandoz IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Sandoz Recent Developments/Updates
2.11 Biocon Biologics
2.11.1 Biocon Biologics Details
2.11.2 Biocon Biologics Major Business
2.11.3 Biocon Biologics IL-23 Receptor Antagonist Product and Services
2.11.4 Biocon Biologics IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Biocon Biologics Recent Developments/Updates
2.12 Celltrion
2.12.1 Celltrion Details
2.12.2 Celltrion Major Business
2.12.3 Celltrion IL-23 Receptor Antagonist Product and Services
2.12.4 Celltrion IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Celltrion Recent Developments/Updates
2.13 Qyuns Therapeutics
2.13.1 Qyuns Therapeutics Details
2.13.2 Qyuns Therapeutics Major Business
2.13.3 Qyuns Therapeutics IL-23 Receptor Antagonist Product and Services
2.13.4 Qyuns Therapeutics IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Qyuns Therapeutics Recent Developments/Updates
2.14 Bio-Thera Solutions
2.14.1 Bio-Thera Solutions Details
2.14.2 Bio-Thera Solutions Major Business
2.14.3 Bio-Thera Solutions IL-23 Receptor Antagonist Product and Services
2.14.4 Bio-Thera Solutions IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Bio-Thera Solutions Recent Developments/Updates
2.15 Huadong Medicine
2.15.1 Huadong Medicine Details
2.15.2 Huadong Medicine Major Business
2.15.3 Huadong Medicine IL-23 Receptor Antagonist Product and Services
2.15.4 Huadong Medicine IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Huadong Medicine Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IL-23 RECEPTOR ANTAGONIST BY MANUFACTURER
3.1 Global IL-23 Receptor Antagonist Sales Quantity by Manufacturer (2021-2026)
3.2 Global IL-23 Receptor Antagonist Revenue by Manufacturer (2021-2026)
3.3 Global IL-23 Receptor Antagonist Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of IL-23 Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 IL-23 Receptor Antagonist Manufacturer Market Share in 2025
3.4.3 Top 6 IL-23 Receptor Antagonist Manufacturer Market Share in 2025
3.5 IL-23 Receptor Antagonist Market: Overall Company Footprint Analysis
3.5.1 IL-23 Receptor Antagonist Market: Region Footprint
3.5.2 IL-23 Receptor Antagonist Market: Company Product Type Footprint
3.5.3 IL-23 Receptor Antagonist Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global IL-23 Receptor Antagonist Market Size by Region
4.1.1 Global IL-23 Receptor Antagonist Sales Quantity by Region (2021-2032)
4.1.2 Global IL-23 Receptor Antagonist Consumption Value by Region (2021-2032)
4.1.3 Global IL-23 Receptor Antagonist Average Price by Region (2021-2032)
4.2 North America IL-23 Receptor Antagonist Consumption Value (2021-2032)
4.3 Europe IL-23 Receptor Antagonist Consumption Value (2021-2032)
4.4 Asia-Pacific IL-23 Receptor Antagonist Consumption Value (2021-2032)
4.5 South America IL-23 Receptor Antagonist Consumption Value (2021-2032)
4.6 Middle East & Africa IL-23 Receptor Antagonist Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
5.2 Global IL-23 Receptor Antagonist Consumption Value by Type (2021-2032)
5.3 Global IL-23 Receptor Antagonist Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
6.2 Global IL-23 Receptor Antagonist Consumption Value by Application (2021-2032)
6.3 Global IL-23 Receptor Antagonist Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
7.2 North America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
7.3 North America IL-23 Receptor Antagonist Market Size by Country
7.3.1 North America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
7.3.2 North America IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
8.2 Europe IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
8.3 Europe IL-23 Receptor Antagonist Market Size by Country
8.3.1 Europe IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
8.3.2 Europe IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific IL-23 Receptor Antagonist Market Size by Region
9.3.1 Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific IL-23 Receptor Antagonist Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
10.2 South America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
10.3 South America IL-23 Receptor Antagonist Market Size by Country
10.3.1 South America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
10.3.2 South America IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa IL-23 Receptor Antagonist Market Size by Country
11.3.1 Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 IL-23 Receptor Antagonist Market Drivers
12.2 IL-23 Receptor Antagonist Market Restraints
12.3 IL-23 Receptor Antagonist Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of IL-23 Receptor Antagonist and Key Manufacturers
13.2 Manufacturing Costs Percentage of IL-23 Receptor Antagonist
13.3 IL-23 Receptor Antagonist Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 IL-23 Receptor Antagonist Typical Distributors
14.3 IL-23 Receptor Antagonist Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global IL-23 Receptor Antagonist Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Ustekinumab
1.3.3 Briakinumab
1.3.4 Tildrakizumab
1.3.5 Guselkumab
1.3.6 Risankizumab
1.3.7 Mirikizumab
1.3.8 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global IL-23 Receptor Antagonist Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Crohn's Disease
1.4.3 Plaque Psoriasis
1.4.4 Psoriatic Arthritis
1.4.5 Other
1.5 Global IL-23 Receptor Antagonist Market Size & Forecast
1.5.1 Global IL-23 Receptor Antagonist Consumption Value (2021 & 2025 & 2032)
1.5.2 Global IL-23 Receptor Antagonist Sales Quantity (2021-2032)
1.5.3 Global IL-23 Receptor Antagonist Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Janssen Pharmaceuticals
2.1.1 Janssen Pharmaceuticals Details
2.1.2 Janssen Pharmaceuticals Major Business
2.1.3 Janssen Pharmaceuticals IL-23 Receptor Antagonist Product and Services
2.1.4 Janssen Pharmaceuticals IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Janssen Pharmaceuticals Recent Developments/Updates
2.2 Sun Pharma
2.2.1 Sun Pharma Details
2.2.2 Sun Pharma Major Business
2.2.3 Sun Pharma IL-23 Receptor Antagonist Product and Services
2.2.4 Sun Pharma IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sun Pharma Recent Developments/Updates
2.3 Almirall
2.3.1 Almirall Details
2.3.2 Almirall Major Business
2.3.3 Almirall IL-23 Receptor Antagonist Product and Services
2.3.4 Almirall IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Almirall Recent Developments/Updates
2.4 China Medical System
2.4.1 China Medical System Details
2.4.2 China Medical System Major Business
2.4.3 China Medical System IL-23 Receptor Antagonist Product and Services
2.4.4 China Medical System IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 China Medical System Recent Developments/Updates
2.5 AbbVie Biotechnology
2.5.1 AbbVie Biotechnology Details
2.5.2 AbbVie Biotechnology Major Business
2.5.3 AbbVie Biotechnology IL-23 Receptor Antagonist Product and Services
2.5.4 AbbVie Biotechnology IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 AbbVie Biotechnology Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly IL-23 Receptor Antagonist Product and Services
2.6.4 Eli Lilly IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Eli Lilly Recent Developments/Updates
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva IL-23 Receptor Antagonist Product and Services
2.7.4 Teva IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Teva Recent Developments/Updates
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen IL-23 Receptor Antagonist Product and Services
2.8.4 Amgen IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Amgen Recent Developments/Updates
2.9 Samsung Bioepis
2.9.1 Samsung Bioepis Details
2.9.2 Samsung Bioepis Major Business
2.9.3 Samsung Bioepis IL-23 Receptor Antagonist Product and Services
2.9.4 Samsung Bioepis IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Samsung Bioepis Recent Developments/Updates
2.10 Sandoz
2.10.1 Sandoz Details
2.10.2 Sandoz Major Business
2.10.3 Sandoz IL-23 Receptor Antagonist Product and Services
2.10.4 Sandoz IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Sandoz Recent Developments/Updates
2.11 Biocon Biologics
2.11.1 Biocon Biologics Details
2.11.2 Biocon Biologics Major Business
2.11.3 Biocon Biologics IL-23 Receptor Antagonist Product and Services
2.11.4 Biocon Biologics IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Biocon Biologics Recent Developments/Updates
2.12 Celltrion
2.12.1 Celltrion Details
2.12.2 Celltrion Major Business
2.12.3 Celltrion IL-23 Receptor Antagonist Product and Services
2.12.4 Celltrion IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Celltrion Recent Developments/Updates
2.13 Qyuns Therapeutics
2.13.1 Qyuns Therapeutics Details
2.13.2 Qyuns Therapeutics Major Business
2.13.3 Qyuns Therapeutics IL-23 Receptor Antagonist Product and Services
2.13.4 Qyuns Therapeutics IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Qyuns Therapeutics Recent Developments/Updates
2.14 Bio-Thera Solutions
2.14.1 Bio-Thera Solutions Details
2.14.2 Bio-Thera Solutions Major Business
2.14.3 Bio-Thera Solutions IL-23 Receptor Antagonist Product and Services
2.14.4 Bio-Thera Solutions IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Bio-Thera Solutions Recent Developments/Updates
2.15 Huadong Medicine
2.15.1 Huadong Medicine Details
2.15.2 Huadong Medicine Major Business
2.15.3 Huadong Medicine IL-23 Receptor Antagonist Product and Services
2.15.4 Huadong Medicine IL-23 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Huadong Medicine Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IL-23 RECEPTOR ANTAGONIST BY MANUFACTURER
3.1 Global IL-23 Receptor Antagonist Sales Quantity by Manufacturer (2021-2026)
3.2 Global IL-23 Receptor Antagonist Revenue by Manufacturer (2021-2026)
3.3 Global IL-23 Receptor Antagonist Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of IL-23 Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 IL-23 Receptor Antagonist Manufacturer Market Share in 2025
3.4.3 Top 6 IL-23 Receptor Antagonist Manufacturer Market Share in 2025
3.5 IL-23 Receptor Antagonist Market: Overall Company Footprint Analysis
3.5.1 IL-23 Receptor Antagonist Market: Region Footprint
3.5.2 IL-23 Receptor Antagonist Market: Company Product Type Footprint
3.5.3 IL-23 Receptor Antagonist Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global IL-23 Receptor Antagonist Market Size by Region
4.1.1 Global IL-23 Receptor Antagonist Sales Quantity by Region (2021-2032)
4.1.2 Global IL-23 Receptor Antagonist Consumption Value by Region (2021-2032)
4.1.3 Global IL-23 Receptor Antagonist Average Price by Region (2021-2032)
4.2 North America IL-23 Receptor Antagonist Consumption Value (2021-2032)
4.3 Europe IL-23 Receptor Antagonist Consumption Value (2021-2032)
4.4 Asia-Pacific IL-23 Receptor Antagonist Consumption Value (2021-2032)
4.5 South America IL-23 Receptor Antagonist Consumption Value (2021-2032)
4.6 Middle East & Africa IL-23 Receptor Antagonist Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
5.2 Global IL-23 Receptor Antagonist Consumption Value by Type (2021-2032)
5.3 Global IL-23 Receptor Antagonist Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
6.2 Global IL-23 Receptor Antagonist Consumption Value by Application (2021-2032)
6.3 Global IL-23 Receptor Antagonist Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
7.2 North America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
7.3 North America IL-23 Receptor Antagonist Market Size by Country
7.3.1 North America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
7.3.2 North America IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
8.2 Europe IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
8.3 Europe IL-23 Receptor Antagonist Market Size by Country
8.3.1 Europe IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
8.3.2 Europe IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific IL-23 Receptor Antagonist Market Size by Region
9.3.1 Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific IL-23 Receptor Antagonist Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
10.2 South America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
10.3 South America IL-23 Receptor Antagonist Market Size by Country
10.3.1 South America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
10.3.2 South America IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa IL-23 Receptor Antagonist Market Size by Country
11.3.1 Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa IL-23 Receptor Antagonist Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 IL-23 Receptor Antagonist Market Drivers
12.2 IL-23 Receptor Antagonist Market Restraints
12.3 IL-23 Receptor Antagonist Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of IL-23 Receptor Antagonist and Key Manufacturers
13.2 Manufacturing Costs Percentage of IL-23 Receptor Antagonist
13.3 IL-23 Receptor Antagonist Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 IL-23 Receptor Antagonist Typical Distributors
14.3 IL-23 Receptor Antagonist Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global IL-23 Receptor Antagonist Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global IL-23 Receptor Antagonist Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Pharmaceuticals Major Business
Table 5. Janssen Pharmaceuticals IL-23 Receptor Antagonist Product and Services
Table 6. Janssen Pharmaceuticals IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Janssen Pharmaceuticals Recent Developments/Updates
Table 8. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Sun Pharma Major Business
Table 10. Sun Pharma IL-23 Receptor Antagonist Product and Services
Table 11. Sun Pharma IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Sun Pharma Recent Developments/Updates
Table 13. Almirall Basic Information, Manufacturing Base and Competitors
Table 14. Almirall Major Business
Table 15. Almirall IL-23 Receptor Antagonist Product and Services
Table 16. Almirall IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Almirall Recent Developments/Updates
Table 18. China Medical System Basic Information, Manufacturing Base and Competitors
Table 19. China Medical System Major Business
Table 20. China Medical System IL-23 Receptor Antagonist Product and Services
Table 21. China Medical System IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. China Medical System Recent Developments/Updates
Table 23. AbbVie Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie Biotechnology Major Business
Table 25. AbbVie Biotechnology IL-23 Receptor Antagonist Product and Services
Table 26. AbbVie Biotechnology IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. AbbVie Biotechnology Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly IL-23 Receptor Antagonist Product and Services
Table 31. Eli Lilly IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. Teva Basic Information, Manufacturing Base and Competitors
Table 34. Teva Major Business
Table 35. Teva IL-23 Receptor Antagonist Product and Services
Table 36. Teva IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Teva Recent Developments/Updates
Table 38. Amgen Basic Information, Manufacturing Base and Competitors
Table 39. Amgen Major Business
Table 40. Amgen IL-23 Receptor Antagonist Product and Services
Table 41. Amgen IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Amgen Recent Developments/Updates
Table 43. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 44. Samsung Bioepis Major Business
Table 45. Samsung Bioepis IL-23 Receptor Antagonist Product and Services
Table 46. Samsung Bioepis IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Samsung Bioepis Recent Developments/Updates
Table 48. Sandoz Basic Information, Manufacturing Base and Competitors
Table 49. Sandoz Major Business
Table 50. Sandoz IL-23 Receptor Antagonist Product and Services
Table 51. Sandoz IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Sandoz Recent Developments/Updates
Table 53. Biocon Biologics Basic Information, Manufacturing Base and Competitors
Table 54. Biocon Biologics Major Business
Table 55. Biocon Biologics IL-23 Receptor Antagonist Product and Services
Table 56. Biocon Biologics IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Biocon Biologics Recent Developments/Updates
Table 58. Celltrion Basic Information, Manufacturing Base and Competitors
Table 59. Celltrion Major Business
Table 60. Celltrion IL-23 Receptor Antagonist Product and Services
Table 61. Celltrion IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Celltrion Recent Developments/Updates
Table 63. Qyuns Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Qyuns Therapeutics Major Business
Table 65. Qyuns Therapeutics IL-23 Receptor Antagonist Product and Services
Table 66. Qyuns Therapeutics IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Qyuns Therapeutics Recent Developments/Updates
Table 68. Bio-Thera Solutions Basic Information, Manufacturing Base and Competitors
Table 69. Bio-Thera Solutions Major Business
Table 70. Bio-Thera Solutions IL-23 Receptor Antagonist Product and Services
Table 71. Bio-Thera Solutions IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Bio-Thera Solutions Recent Developments/Updates
Table 73. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 74. Huadong Medicine Major Business
Table 75. Huadong Medicine IL-23 Receptor Antagonist Product and Services
Table 76. Huadong Medicine IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Huadong Medicine Recent Developments/Updates
Table 78. Global IL-23 Receptor Antagonist Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 79. Global IL-23 Receptor Antagonist Revenue by Manufacturer (2021-2026) & (USD Million)
Table 80. Global IL-23 Receptor Antagonist Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 81. Market Position of Manufacturers in IL-23 Receptor Antagonist, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 82. Head Office and IL-23 Receptor Antagonist Production Site of Key Manufacturer
Table 83. IL-23 Receptor Antagonist Market: Company Product Type Footprint
Table 84. IL-23 Receptor Antagonist Market: Company Product Application Footprint
Table 85. IL-23 Receptor Antagonist New Market Entrants and Barriers to Market Entry
Table 86. IL-23 Receptor Antagonist Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global IL-23 Receptor Antagonist Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 88. Global IL-23 Receptor Antagonist Sales Quantity by Region (2021-2026) & (K Units)
Table 89. Global IL-23 Receptor Antagonist Sales Quantity by Region (2027-2032) & (K Units)
Table 90. Global IL-23 Receptor Antagonist Consumption Value by Region (2021-2026) & (USD Million)
Table 91. Global IL-23 Receptor Antagonist Consumption Value by Region (2027-2032) & (USD Million)
Table 92. Global IL-23 Receptor Antagonist Average Price by Region (2021-2026) & (US$/Unit)
Table 93. Global IL-23 Receptor Antagonist Average Price by Region (2027-2032) & (US$/Unit)
Table 94. Global IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 95. Global IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 96. Global IL-23 Receptor Antagonist Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Global IL-23 Receptor Antagonist Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Global IL-23 Receptor Antagonist Average Price by Type (2021-2026) & (US$/Unit)
Table 99. Global IL-23 Receptor Antagonist Average Price by Type (2027-2032) & (US$/Unit)
Table 100. Global IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 101. Global IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 102. Global IL-23 Receptor Antagonist Consumption Value by Application (2021-2026) & (USD Million)
Table 103. Global IL-23 Receptor Antagonist Consumption Value by Application (2027-2032) & (USD Million)
Table 104. Global IL-23 Receptor Antagonist Average Price by Application (2021-2026) & (US$/Unit)
Table 105. Global IL-23 Receptor Antagonist Average Price by Application (2027-2032) & (US$/Unit)
Table 106. North America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 107. North America IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 108. North America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 109. North America IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 110. North America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2026) & (K Units)
Table 111. North America IL-23 Receptor Antagonist Sales Quantity by Country (2027-2032) & (K Units)
Table 112. North America IL-23 Receptor Antagonist Consumption Value by Country (2021-2026) & (USD Million)
Table 113. North America IL-23 Receptor Antagonist Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Europe IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 115. Europe IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 116. Europe IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 117. Europe IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 118. Europe IL-23 Receptor Antagonist Sales Quantity by Country (2021-2026) & (K Units)
Table 119. Europe IL-23 Receptor Antagonist Sales Quantity by Country (2027-2032) & (K Units)
Table 120. Europe IL-23 Receptor Antagonist Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Europe IL-23 Receptor Antagonist Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 123. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 124. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 125. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 126. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Region (2021-2026) & (K Units)
Table 127. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Region (2027-2032) & (K Units)
Table 128. Asia-Pacific IL-23 Receptor Antagonist Consumption Value by Region (2021-2026) & (USD Million)
Table 129. Asia-Pacific IL-23 Receptor Antagonist Consumption Value by Region (2027-2032) & (USD Million)
Table 130. South America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 131. South America IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 132. South America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 133. South America IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 134. South America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2026) & (K Units)
Table 135. South America IL-23 Receptor Antagonist Sales Quantity by Country (2027-2032) & (K Units)
Table 136. South America IL-23 Receptor Antagonist Consumption Value by Country (2021-2026) & (USD Million)
Table 137. South America IL-23 Receptor Antagonist Consumption Value by Country (2027-2032) & (USD Million)
Table 138. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 139. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 140. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 141. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 142. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Country (2021-2026) & (K Units)
Table 143. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Country (2027-2032) & (K Units)
Table 144. Middle East & Africa IL-23 Receptor Antagonist Consumption Value by Country (2021-2026) & (USD Million)
Table 145. Middle East & Africa IL-23 Receptor Antagonist Consumption Value by Country (2027-2032) & (USD Million)
Table 146. IL-23 Receptor Antagonist Raw Material
Table 147. Key Manufacturers of IL-23 Receptor Antagonist Raw Materials
Table 148. IL-23 Receptor Antagonist Typical Distributors
Table 149. IL-23 Receptor Antagonist Typical Customers
Table 1. Global IL-23 Receptor Antagonist Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global IL-23 Receptor Antagonist Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Pharmaceuticals Major Business
Table 5. Janssen Pharmaceuticals IL-23 Receptor Antagonist Product and Services
Table 6. Janssen Pharmaceuticals IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Janssen Pharmaceuticals Recent Developments/Updates
Table 8. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Sun Pharma Major Business
Table 10. Sun Pharma IL-23 Receptor Antagonist Product and Services
Table 11. Sun Pharma IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Sun Pharma Recent Developments/Updates
Table 13. Almirall Basic Information, Manufacturing Base and Competitors
Table 14. Almirall Major Business
Table 15. Almirall IL-23 Receptor Antagonist Product and Services
Table 16. Almirall IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Almirall Recent Developments/Updates
Table 18. China Medical System Basic Information, Manufacturing Base and Competitors
Table 19. China Medical System Major Business
Table 20. China Medical System IL-23 Receptor Antagonist Product and Services
Table 21. China Medical System IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. China Medical System Recent Developments/Updates
Table 23. AbbVie Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie Biotechnology Major Business
Table 25. AbbVie Biotechnology IL-23 Receptor Antagonist Product and Services
Table 26. AbbVie Biotechnology IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. AbbVie Biotechnology Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly IL-23 Receptor Antagonist Product and Services
Table 31. Eli Lilly IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. Teva Basic Information, Manufacturing Base and Competitors
Table 34. Teva Major Business
Table 35. Teva IL-23 Receptor Antagonist Product and Services
Table 36. Teva IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Teva Recent Developments/Updates
Table 38. Amgen Basic Information, Manufacturing Base and Competitors
Table 39. Amgen Major Business
Table 40. Amgen IL-23 Receptor Antagonist Product and Services
Table 41. Amgen IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Amgen Recent Developments/Updates
Table 43. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 44. Samsung Bioepis Major Business
Table 45. Samsung Bioepis IL-23 Receptor Antagonist Product and Services
Table 46. Samsung Bioepis IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Samsung Bioepis Recent Developments/Updates
Table 48. Sandoz Basic Information, Manufacturing Base and Competitors
Table 49. Sandoz Major Business
Table 50. Sandoz IL-23 Receptor Antagonist Product and Services
Table 51. Sandoz IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Sandoz Recent Developments/Updates
Table 53. Biocon Biologics Basic Information, Manufacturing Base and Competitors
Table 54. Biocon Biologics Major Business
Table 55. Biocon Biologics IL-23 Receptor Antagonist Product and Services
Table 56. Biocon Biologics IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Biocon Biologics Recent Developments/Updates
Table 58. Celltrion Basic Information, Manufacturing Base and Competitors
Table 59. Celltrion Major Business
Table 60. Celltrion IL-23 Receptor Antagonist Product and Services
Table 61. Celltrion IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Celltrion Recent Developments/Updates
Table 63. Qyuns Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Qyuns Therapeutics Major Business
Table 65. Qyuns Therapeutics IL-23 Receptor Antagonist Product and Services
Table 66. Qyuns Therapeutics IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Qyuns Therapeutics Recent Developments/Updates
Table 68. Bio-Thera Solutions Basic Information, Manufacturing Base and Competitors
Table 69. Bio-Thera Solutions Major Business
Table 70. Bio-Thera Solutions IL-23 Receptor Antagonist Product and Services
Table 71. Bio-Thera Solutions IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Bio-Thera Solutions Recent Developments/Updates
Table 73. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 74. Huadong Medicine Major Business
Table 75. Huadong Medicine IL-23 Receptor Antagonist Product and Services
Table 76. Huadong Medicine IL-23 Receptor Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Huadong Medicine Recent Developments/Updates
Table 78. Global IL-23 Receptor Antagonist Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 79. Global IL-23 Receptor Antagonist Revenue by Manufacturer (2021-2026) & (USD Million)
Table 80. Global IL-23 Receptor Antagonist Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 81. Market Position of Manufacturers in IL-23 Receptor Antagonist, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 82. Head Office and IL-23 Receptor Antagonist Production Site of Key Manufacturer
Table 83. IL-23 Receptor Antagonist Market: Company Product Type Footprint
Table 84. IL-23 Receptor Antagonist Market: Company Product Application Footprint
Table 85. IL-23 Receptor Antagonist New Market Entrants and Barriers to Market Entry
Table 86. IL-23 Receptor Antagonist Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global IL-23 Receptor Antagonist Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 88. Global IL-23 Receptor Antagonist Sales Quantity by Region (2021-2026) & (K Units)
Table 89. Global IL-23 Receptor Antagonist Sales Quantity by Region (2027-2032) & (K Units)
Table 90. Global IL-23 Receptor Antagonist Consumption Value by Region (2021-2026) & (USD Million)
Table 91. Global IL-23 Receptor Antagonist Consumption Value by Region (2027-2032) & (USD Million)
Table 92. Global IL-23 Receptor Antagonist Average Price by Region (2021-2026) & (US$/Unit)
Table 93. Global IL-23 Receptor Antagonist Average Price by Region (2027-2032) & (US$/Unit)
Table 94. Global IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 95. Global IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 96. Global IL-23 Receptor Antagonist Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Global IL-23 Receptor Antagonist Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Global IL-23 Receptor Antagonist Average Price by Type (2021-2026) & (US$/Unit)
Table 99. Global IL-23 Receptor Antagonist Average Price by Type (2027-2032) & (US$/Unit)
Table 100. Global IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 101. Global IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 102. Global IL-23 Receptor Antagonist Consumption Value by Application (2021-2026) & (USD Million)
Table 103. Global IL-23 Receptor Antagonist Consumption Value by Application (2027-2032) & (USD Million)
Table 104. Global IL-23 Receptor Antagonist Average Price by Application (2021-2026) & (US$/Unit)
Table 105. Global IL-23 Receptor Antagonist Average Price by Application (2027-2032) & (US$/Unit)
Table 106. North America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 107. North America IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 108. North America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 109. North America IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 110. North America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2026) & (K Units)
Table 111. North America IL-23 Receptor Antagonist Sales Quantity by Country (2027-2032) & (K Units)
Table 112. North America IL-23 Receptor Antagonist Consumption Value by Country (2021-2026) & (USD Million)
Table 113. North America IL-23 Receptor Antagonist Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Europe IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 115. Europe IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 116. Europe IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 117. Europe IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 118. Europe IL-23 Receptor Antagonist Sales Quantity by Country (2021-2026) & (K Units)
Table 119. Europe IL-23 Receptor Antagonist Sales Quantity by Country (2027-2032) & (K Units)
Table 120. Europe IL-23 Receptor Antagonist Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Europe IL-23 Receptor Antagonist Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 123. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 124. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 125. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 126. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Region (2021-2026) & (K Units)
Table 127. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity by Region (2027-2032) & (K Units)
Table 128. Asia-Pacific IL-23 Receptor Antagonist Consumption Value by Region (2021-2026) & (USD Million)
Table 129. Asia-Pacific IL-23 Receptor Antagonist Consumption Value by Region (2027-2032) & (USD Million)
Table 130. South America IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 131. South America IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 132. South America IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 133. South America IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 134. South America IL-23 Receptor Antagonist Sales Quantity by Country (2021-2026) & (K Units)
Table 135. South America IL-23 Receptor Antagonist Sales Quantity by Country (2027-2032) & (K Units)
Table 136. South America IL-23 Receptor Antagonist Consumption Value by Country (2021-2026) & (USD Million)
Table 137. South America IL-23 Receptor Antagonist Consumption Value by Country (2027-2032) & (USD Million)
Table 138. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Type (2021-2026) & (K Units)
Table 139. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Type (2027-2032) & (K Units)
Table 140. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Application (2021-2026) & (K Units)
Table 141. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Application (2027-2032) & (K Units)
Table 142. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Country (2021-2026) & (K Units)
Table 143. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity by Country (2027-2032) & (K Units)
Table 144. Middle East & Africa IL-23 Receptor Antagonist Consumption Value by Country (2021-2026) & (USD Million)
Table 145. Middle East & Africa IL-23 Receptor Antagonist Consumption Value by Country (2027-2032) & (USD Million)
Table 146. IL-23 Receptor Antagonist Raw Material
Table 147. Key Manufacturers of IL-23 Receptor Antagonist Raw Materials
Table 148. IL-23 Receptor Antagonist Typical Distributors
Table 149. IL-23 Receptor Antagonist Typical Customers
LIST OF FIGURES
Figure 1. IL-23 Receptor Antagonist Picture
Figure 2. Global IL-23 Receptor Antagonist Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global IL-23 Receptor Antagonist Revenue Market Share by Type in 2025
Figure 4. Ustekinumab Examples
Figure 5. Briakinumab Examples
Figure 6. Tildrakizumab Examples
Figure 7. Guselkumab Examples
Figure 8. Risankizumab Examples
Figure 9. Mirikizumab Examples
Figure 10. Other Examples
Figure 11. Other Examples
Figure 12. Global IL-23 Receptor Antagonist Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 13. Global IL-23 Receptor Antagonist Revenue Market Share by Application in 2025
Figure 14. Crohn's Disease Examples
Figure 15. Plaque Psoriasis Examples
Figure 16. Psoriatic Arthritis Examples
Figure 17. Other Examples
Figure 18. Global IL-23 Receptor Antagonist Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global IL-23 Receptor Antagonist Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global IL-23 Receptor Antagonist Sales Quantity (2021-2032) & (K Units)
Figure 21. Global IL-23 Receptor Antagonist Price (2021-2032) & (US$/Unit)
Figure 22. Global IL-23 Receptor Antagonist Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global IL-23 Receptor Antagonist Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of IL-23 Receptor Antagonist by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 IL-23 Receptor Antagonist Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 IL-23 Receptor Antagonist Manufacturer (Revenue) Market Share in 2025
Figure 27. Global IL-23 Receptor Antagonist Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global IL-23 Receptor Antagonist Consumption Value Market Share by Region (2021-2032)
Figure 29. North America IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 32. South America IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 34. Global IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global IL-23 Receptor Antagonist Consumption Value Market Share by Type (2021-2032)
Figure 36. Global IL-23 Receptor Antagonist Average Price by Type (2021-2032) & (US$/Unit)
Figure 37. Global IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global IL-23 Receptor Antagonist Revenue Market Share by Application (2021-2032)
Figure 39. Global IL-23 Receptor Antagonist Average Price by Application (2021-2032) & (US$/Unit)
Figure 40. North America IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America IL-23 Receptor Antagonist Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America IL-23 Receptor Antagonist Consumption Value Market Share by Country (2021-2032)
Figure 44. United States IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe IL-23 Receptor Antagonist Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe IL-23 Receptor Antagonist Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 52. France IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific IL-23 Receptor Antagonist Consumption Value Market Share by Region (2021-2032)
Figure 60. China IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 63. India IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 66. South America IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America IL-23 Receptor Antagonist Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America IL-23 Receptor Antagonist Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa IL-23 Receptor Antagonist Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 80. IL-23 Receptor Antagonist Market Drivers
Figure 81. IL-23 Receptor Antagonist Market Restraints
Figure 82. IL-23 Receptor Antagonist Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of IL-23 Receptor Antagonist in 2025
Figure 85. Manufacturing Process Analysis of IL-23 Receptor Antagonist
Figure 86. IL-23 Receptor Antagonist Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Figure 1. IL-23 Receptor Antagonist Picture
Figure 2. Global IL-23 Receptor Antagonist Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global IL-23 Receptor Antagonist Revenue Market Share by Type in 2025
Figure 4. Ustekinumab Examples
Figure 5. Briakinumab Examples
Figure 6. Tildrakizumab Examples
Figure 7. Guselkumab Examples
Figure 8. Risankizumab Examples
Figure 9. Mirikizumab Examples
Figure 10. Other Examples
Figure 11. Other Examples
Figure 12. Global IL-23 Receptor Antagonist Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 13. Global IL-23 Receptor Antagonist Revenue Market Share by Application in 2025
Figure 14. Crohn's Disease Examples
Figure 15. Plaque Psoriasis Examples
Figure 16. Psoriatic Arthritis Examples
Figure 17. Other Examples
Figure 18. Global IL-23 Receptor Antagonist Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global IL-23 Receptor Antagonist Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global IL-23 Receptor Antagonist Sales Quantity (2021-2032) & (K Units)
Figure 21. Global IL-23 Receptor Antagonist Price (2021-2032) & (US$/Unit)
Figure 22. Global IL-23 Receptor Antagonist Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global IL-23 Receptor Antagonist Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of IL-23 Receptor Antagonist by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 IL-23 Receptor Antagonist Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 IL-23 Receptor Antagonist Manufacturer (Revenue) Market Share in 2025
Figure 27. Global IL-23 Receptor Antagonist Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global IL-23 Receptor Antagonist Consumption Value Market Share by Region (2021-2032)
Figure 29. North America IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 32. South America IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 34. Global IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global IL-23 Receptor Antagonist Consumption Value Market Share by Type (2021-2032)
Figure 36. Global IL-23 Receptor Antagonist Average Price by Type (2021-2032) & (US$/Unit)
Figure 37. Global IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global IL-23 Receptor Antagonist Revenue Market Share by Application (2021-2032)
Figure 39. Global IL-23 Receptor Antagonist Average Price by Application (2021-2032) & (US$/Unit)
Figure 40. North America IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America IL-23 Receptor Antagonist Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America IL-23 Receptor Antagonist Consumption Value Market Share by Country (2021-2032)
Figure 44. United States IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe IL-23 Receptor Antagonist Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe IL-23 Receptor Antagonist Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 52. France IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific IL-23 Receptor Antagonist Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific IL-23 Receptor Antagonist Consumption Value Market Share by Region (2021-2032)
Figure 60. China IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 63. India IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 66. South America IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America IL-23 Receptor Antagonist Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America IL-23 Receptor Antagonist Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa IL-23 Receptor Antagonist Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa IL-23 Receptor Antagonist Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa IL-23 Receptor Antagonist Consumption Value (2021-2032) & (USD Million)
Figure 80. IL-23 Receptor Antagonist Market Drivers
Figure 81. IL-23 Receptor Antagonist Market Restraints
Figure 82. IL-23 Receptor Antagonist Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of IL-23 Receptor Antagonist in 2025
Figure 85. Manufacturing Process Analysis of IL-23 Receptor Antagonist
Figure 86. IL-23 Receptor Antagonist Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source